The Potential Contribution of MyomiRs miR-133a-3p, -133b, and -206 Dysregulation in Cardiovascular Disease Risk
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312772 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Paolina Crocco und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Ecology and Earth Sciences, University of Calabria, 87036 Rende, Italy. Hauptthemen laut MEDLINE: MicroRNAs, Cardiovascular Diseases, Biomarkers. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, Next Generation EU.
Abstract (Originalsprache)
Cardiovascular disease (CVD) is a major global health concern. The number of people with CVD is expected to rise due to aging populations and increasing risk factors such as obesity and diabetes. Identifying new molecular markers is crucial for early diagnosis and treatment. Among these, plasma levels of some miRNAs, specifically expressed in cardiac and skeletal muscle, known as myomiRs, have gained attention for their roles in cardiovascular health. This study analyzed the plasma levels of miR-133a-3p, -133b, and -206 in the pathogenesis of cardiovascular diseases. Using a case–control study design with patients recruited from several nursing homes from Calabria (southern Italy) characterized by different types of CVD compared with non-CVD controls, we found downregulation of miR-133a-3p in heart failure and miR-133b in stroke, along with the overall decreased expression of miR-133b and miR-206 in CVD patients, although they showed low specificity as biomarkers of CVD (as based on ROC analysis). In silico functional characterization of their targets and signaling pathways revealed their involvement in critical cardiovascular processes. Although further research is necessary to fully elucidate their mechanisms and clinical utility, the findings reported here may provide insight into the potential contribution of myomiRs in the cardiovascular injury framework, also offering indications for new research directions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Ecology and Earth Sciences, University of Calabria, 87036 Rende, Italy.
- Unit of Geriatric Medicine, Italian National Research Center on Aging (INRCA-IRCCS), 87100 Cosenza, Italy.
ORCID-Profile: Paolina Crocco, Alberto Montesanto, Ersilia Paparazzo, Luca Soraci, Giuseppe Passarino, Giuseppina Rose
Förderung
- Italian Ministry of Health
- Next Generation EU
Zitieren
APA
Crocco, P., Montesanto, A., La Grotta, R., Paparazzo, E., Soraci, L., Dato, S., Passarino, G., & Rose, G. (2024). The Potential Contribution of MyomiRs miR-133a-3p, -133b, and -206 Dysregulation in Cardiovascular Disease Risk. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312772
Vancouver
Crocco P, Montesanto A, La Grotta R, Paparazzo E, Soraci L, Dato S, et al. The Potential Contribution of MyomiRs miR-133a-3p, -133b, and -206 Dysregulation in Cardiovascular Disease Risk. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312772
BibTeX
@article{Crocco2024,
author = {Crocco, Paolina and Montesanto, Alberto and La Grotta, Rossella and Paparazzo, Ersilia and Soraci, Luca and Dato, Serena and Passarino, Giuseppe and Rose, Giuseppina},
title = {The Potential Contribution of MyomiRs miR-133a-3p, -133b, and -206 Dysregulation in Cardiovascular Disease Risk},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312772}
}
EUVIMED